Literature DB >> 28891237

The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project.

Maria Dall'Era1, Miriam G Cisternas2, Kurt Snipes3, Lisa J Herrinton4, Caroline Gordon5, Charles G Helmick6.   

Abstract

OBJECTIVE: Estimates of the incidence and prevalence of systemic lupus erythematosus (SLE) in the US have varied widely. The purpose of this study was to conduct the California Lupus Surveillance Project (CLSP) to determine credible estimates of SLE incidence and prevalence, with a special focus on Hispanics and Asians.
METHODS: The CLSP, which is funded by the Centers for Disease Control and Prevention, is a population-based registry of individuals with SLE residing in San Francisco County, CA, from January 1, 2007 through December 31, 2009. Data sources included hospitals, rheumatologists, nephrologists, commercial laboratories, and a state hospital discharge database. We abstracted medical records to ascertain SLE cases, which we defined as patients who met ≥4 of the 11 American College of Rheumatology classification criteria for SLE. We estimated crude and age-standardized incidence and prevalence, which were stratified by sex and race/ethnicity.
RESULTS: The overall age-standardized annual incidence rate was 4.6 per 100,000 person-years. The average annual period prevalence was 84.8 per 100,000 persons. The age-standardized incidence rate in women and men was 8.6 and 0.7 per 100,000 person-years, respectively. This rate was highest among black women (30.5), followed by Hispanic women (8.9), Asian women (7.2), and white women (5.3). The age-standardized prevalence in women per 100,000 persons was 458.1 in blacks, 177.9 in Hispanics, 149.7 in Asians, and 109.8 in whites. Capture-recapture modeling estimated 33 additional incident cases and 147 additional prevalent cases.
CONCLUSION: Comprehensive methods that include intensive case-finding provide more credible estimates of SLE in Hispanics and Asians, and confirm racial and ethnic disparities in SLE. The disease burden of SLE is highest in black women, followed by Hispanic women, Asian women, and white women.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Year:  2017        PMID: 28891237     DOI: 10.1002/art.40191

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  52 in total

1.  Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences.

Authors:  Taylor Olmsted Kim; Amanda B Grimes; Susan E Kirk; Megan M Gilbert; Helen D Reed; Kristen A Staggers; Lauryn A Walker; Abinaya Arulselvan; A Sarah Cohen; Michele P Lambert; Jenny M Despotovic
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 2.  Epidemiology of systemic lupus erythematosus: an update.

Authors:  George Stojan; Michelle Petri
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

3.  Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.

Authors:  David H Chae; Connor D Martz; Thomas E Fuller-Rowell; Erica C Spears; Tianqi Tenchi Gao Smith; Evelyn A Hunter; Cristina Drenkard; S Sam Lim
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

4.  Mediation of Adverse Pregnancy Outcomes in Autoimmune Conditions by Pregnancy Complications: A Mediation Analysis of Autoimmune Conditions and Adverse Pregnancy Outcomes.

Authors:  Gretchen Bandoli; Namrata Singh; Jennifer Strouse; Rebecca J Baer; Brittney M Donovan; Sky K Feuer; Nichole Nidey; Kelli K Ryckman; Laura L Jelliffe-Pawlowski; Christina D Chambers
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-01-09       Impact factor: 4.794

5.  Psychometric Evaluation of the National Institutes of Health Patient-Reported Outcomes Measurement Information System in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort.

Authors:  Patricia Katz; Jinoos Yazdany; Laura Trupin; Stephanie Rush; Charles G Helmick; Louise B Murphy; Cristina Lanata; Lindsey A Criswell; Maria Dall'Era
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-05       Impact factor: 4.794

6.  Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis.

Authors:  Andrea Fava; Jill Buyon; Chandra Mohan; Ting Zhang; H Michael Belmont; Peter Izmirly; Robert Clancy; Jose Monroy Trujillo; Derek Fine; Yuji Zhang; Laurence Magder; Deepak A Rao; Arnon Arazi; Celine C Berthier; Anne Davidson; Betty Diamond; Nir Hacohen; David Wofsy; William Apruzzese; Soumya Raychaudhuri; Michelle Petri
Journal:  JCI Insight       Date:  2020-06-18

7.  The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County.

Authors:  Peter M Izmirly; Jill P Buyon; Isabella Wan; H Michael Belmont; Sara Sahl; Jane E Salmon; Anca Askanase; Joan M Bathon; Laura Geraldino-Pardilla; Yousaf Ali; Ellen M Ginzler; Chaim Putterman; Caroline Gordon; Charles G Helmick; Hilary Parton
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-05-23       Impact factor: 4.794

8.  The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.

Authors:  Ann E Clarke; Jinoos Yazdany; Shaum M Kabadi; Emily Durden; Isabelle Winer; Kirstin Griffing; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2020-05-23       Impact factor: 5.532

9.  Dexamethasone prodrug nanomedicine (ZSJ-0228) treatment significantly reduces lupus nephritis in mice without measurable side effects - A 5-month study.

Authors:  Zhifeng Zhao; Zhenshan Jia; Kirk W Foster; Xin Wei; Fangfang Qiao; Haochen Jiang; Yan Jin; Guojuan Li; Ningrong Chen; Gang Zhao; Geoffrey M Thiele; Jennifer L Medlin; James R O'Dell; Dong Wang
Journal:  Nanomedicine       Date:  2020-09-24       Impact factor: 5.307

10.  Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus.

Authors:  May Y Choi; Jill Hahn; Susan Malspeis; Emma F Stevens; Elizabeth W Karlson; Jeffrey A Sparks; Kazuki Yoshida; Laura Kubzansky; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2022-01-11       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.